Drugs / H2N2 1960 AA ca recombinant vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00722774 | ? → Sep 2008 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H2N2 1960 AA ca recombinant vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00722774 ↗ |
| Modality | Vaccine | “Live Attenuated Virus Vaccine Candidate” NCT00722774 ↗ |
| Route | Intranasal | “Approximately 0.2 ml of 10\^7 TCID50 doses of vaccine administered intranasally” NCT00722774 ↗ |